Anti-PD1 or anti-PD-L1 antibodies alone or in combination with chemotherapy first-line treatment of advanced non-small cell lung cancer

Thorac Cancer. 2022 Apr;13(7):1104-1105. doi: 10.1111/1759-7714.14358. Epub 2022 Feb 24.

Authors

Xuexia Zhang¹, Xiaoping Cai², Hao Zheng²

Affiliations

¹ Department Internal Medicine, Sixth affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, PR China.
² Department of Respiratory and Intensive Care Unit, Sixth affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, PR China.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Lung Neoplasms* / drug therapy

Substances

B7-H1 Antigen